| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 16.315 | 1.413 | 2.061 | 22.358 | 29.340 | 29.677 |
| Total Income - EUR | - | - | - | 0 | 22.835 | 1.413 | 2.061 | 22.362 | 29.999 | 29.678 |
| Total Expenses - EUR | - | - | - | 1.604 | 12.552 | 4.006 | 3.463 | 17.168 | 15.755 | 22.219 |
| Gross Profit/Loss - EUR | - | - | - | -1.604 | 10.283 | -2.593 | -1.402 | 5.194 | 14.244 | 7.458 |
| Net Profit/Loss - EUR | - | - | - | -1.604 | 10.121 | -2.606 | -1.422 | 4.970 | 13.950 | 7.206 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bogdan & Theo Medtrans S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 4.712 | 2.962 | 1.321 | 0 | 0 | 4.432 | 2.811 |
| Current Assets | - | - | - | 245 | 9.776 | 4.501 | 5.412 | 5.973 | 16.484 | 24.188 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 43 | 316 | 0 | 0 | 0 | 0 | 235 |
| Cash | - | - | - | 202 | 9.460 | 4.501 | 5.412 | 5.973 | 16.484 | 23.953 |
| Shareholders Funds | - | - | - | -1.561 | 8.590 | 5.822 | 4.270 | 4.985 | 18.919 | 26.020 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 6.518 | 4.148 | 0 | 1.142 | 988 | 1.997 | 979 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4932 - 4932" | |||||||||
| CAEN Financial Year |
4932
|
|||||||||
Comments - Bogdan & Theo Medtrans S.r.l.